About McDermott
McDermott Recognized as a Global Market Leader in Chambers High Net Worth 2024
Navigating the Pharma and Medtech Industries: Key Investment and Operational Drivers
Supreme Court Sides with Starbucks in Blow to Union Activists
Labour’s Dirty Money Crackdown ‘Will Drive Away Legitimate Wealth Creators’
April 8, 2024
McDermott Further Strengthens London Transactions Practice With Another Private Equity Partner
March 14, 2024
McDermott Expands Litigation Practice, Eyes White-Collar and Government Investigation Growth Opportunities
May 2, 2024
McDermott’s Aymen Mahmoud to Lead the Firm’s Next Stage of Growth in London
July 25, 2024
India Business Law Journal Recognizes McDermott as a “Significant Player”; Names Two Partners to Its International A-List
June 25, 2024
Private Equity Eyes Creative Solutions to FTC Non-Compete Ban’s Impact
July 17, 2024
FTC, State Scrutiny of Noncompetes Shifts Labor Market
July 18, 2024
State of 2024 Energy Dealmaking: Midyear Report
July 23, 2024
McDermott Represents Valinor Pharma in $250 Million Sale to Grünenthal
McDermott Advises Main Capital Partners on Take-over of US-based DevOps software provider Flexagon
McDermott Recognized in Bloomberg Law’s DEI Framework for Fourth Consecutive Year
"We have built up a strong client base"
July 22, 2024
McDermott Comment | The King's Speech: VAT to be Paid by Private Schools
McDermott Comment | The King's Speech: Workers’ Rights
1 Year at the UPC: Implications for Transatlantic Disputes
July 19, 2024
McDermott Advises KRÜGER GROUP on the Acquisition of Hermes Süssstoff
McDermott advises HF Private Debt-backed BioneXX on Sale of BeLive to USP Group
SAIGroup’s Acquisition of Get Well
McDermott Represents Applied DNA Sciences, Inc. in its $12 Million Public Offering
McDermott Represents Inhibikase Therapeutics in its $4 Million Registered Direct Offering
Mark Schreiber Named a Go To Cybersecurity & Data Privacy Lawyer by Massachusetts Lawyers Weekly for a Second Time